These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16770743)

  • 1. Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease.
    Ding Q; Markesbery WR; Cecarini V; Keller JN
    Neurochem Res; 2006 May; 31(5):705-10. PubMed ID: 16770743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosome dysfunction is an early event in Alzheimer's disease.
    Ding Q; Markesbery WR; Chen Q; Li F; Keller JN
    J Neurosci; 2005 Oct; 25(40):9171-5. PubMed ID: 16207876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
    Cenini G; Sultana R; Memo M; Butterfield DA
    J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
    Lovell MA; Markesbery WR
    J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative inactivation of the proteasome in Alzheimer's disease.
    Cecarini V; Ding Q; Keller JN
    Free Radic Res; 2007 Jun; 41(6):673-80. PubMed ID: 17516240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased 5S rRNA oxidation in Alzheimer's disease.
    Ding Q; Zhu H; Zhang B; Soriano A; Burns R; Markesbery WR
    J Alzheimers Dis; 2012; 29(1):201-9. PubMed ID: 22232003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
    Peng S; Wuu J; Mufson EJ; Fahnestock M
    J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
    Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
    Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
    Butterfield DA; Poon HF; St Clair D; Keller JN; Pierce WM; Klein JB; Markesbery WR
    Neurobiol Dis; 2006 May; 22(2):223-32. PubMed ID: 16466929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression.
    Di Domenico F; Owen JB; Sultana R; Sowell RA; Perluigi M; Cini C; Cai J; Pierce WM; Butterfield DA
    J Neurosci Res; 2010 Dec; 88(16):3566-77. PubMed ID: 20936705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome.
    Hernández-Ortega K; Garcia-Esparcia P; Gil L; Lucas JJ; Ferrer I
    Brain Pathol; 2016 Sep; 26(5):593-605. PubMed ID: 26512942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
    Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
    Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Oxidative Stress on Ribosomes: From Injury to Regulation.
    Shcherbik N; Pestov DG
    Cells; 2019 Nov; 8(11):. PubMed ID: 31684095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered spontaneous activity in Alzheimer's disease and mild cognitive impairment revealed by Regional Homogeneity.
    Zhang Z; Liu Y; Jiang T; Zhou B; An N; Dai H; Wang P; Niu Y; Wang L; Zhang X
    Neuroimage; 2012 Jan; 59(2):1429-40. PubMed ID: 21907292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment.
    Valla J; Schneider L; Niedzielko T; Coon KD; Caselli R; Sabbagh MN; Ahern GL; Baxter L; Alexander G; Walker DG; Reiman EM
    Mitochondrion; 2006 Dec; 6(6):323-30. PubMed ID: 17123871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
    Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidatively modified RNA in mild cognitive impairment.
    Lovell MA; Markesbery WR
    Neurobiol Dis; 2008 Feb; 29(2):169-75. PubMed ID: 17920285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between episodic memory and resting-state brain functional connectivity network in patients with Alzheimer's disease and mild cognition impairment].
    Wu QJ; Guo ZJ; Liu SE; Yu HQ; Chen J; Yang HM
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(23):1795-800. PubMed ID: 24124712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.